AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
01 August 2023 - 6:01AM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative
medical technology company focused on restoring healthy blood flow
in the body’s vascular system, expanding cancer treatment options
and improving quality of life for patients, today announced that
Jim Clemmer, President and Chief Executive Officer, and Stephen
Trowbridge, Executive Vice President and Chief Financial Officer,
will participate in a fireside chat at the Canaccord Genuity 43rd
Annual Growth Conference at 8:00 a.m. ET on Wednesday, August 9,
2023.
A live webcast of the fireside chat will be accessible through
the “Investors” section of the Company’s website at
www.angiodynamics.com and will be available for replay following
the event.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology
company focused on restoring healthy blood flow in the body’s
vascular system, expanding cancer treatment options and improving
quality of life for patients.
The Company’s innovative technologies and devices are chosen by
talented physicians in fast-growing healthcare markets to treat
unmet patient needs. For more information, visit
www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230731261073/en/
Investor Contact: AngioDynamics, Inc. Stephen Trowbridge,
Executive Vice President & CFO (518) 795-1408
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From May 2024 to Jun 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Jun 2023 to Jun 2024